# Mahana Therapeutics, Inc.

- Location (FDA's records): San Francisco, CA
- FDA decisions: 2 (2020–2021): 1 510(k) clearance and 1 De Novo grant
- Product codes: QMY (2)
- Predicates its devices cite: 1 (1 its own); citations of its devices by later devices: 2 (1 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms that cite its devices most
- Metame Health, Inc.: 1 (https://510kreport.com/company/metame-health)

## Its most-cited devices
- DEN200029: Parallel (2020), cited by 2

## Recent decisions
- K211372: Mahana Parallel Digital Cognitive Behavioral Therapy (CBT) Mobile Application for Irritable Bowel Syndrome (IBS) (Jun 2, 2021)
- DEN200029: Parallel (Nov 25, 2020)

Source page: https://510kreport.com/company/mahana-therapeutics